Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles

May 4th, 2007

Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles

Abstract:
Midatech Group Ltd. has announced the opening of its specialist design and manufacturing facility for cGMP grade nanoparticles in Bilbao, Spain.

Midatech Biogune S.L. is the world's first cGMP grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications.

Staffed by an experienced, multi-disciplined team, the plant will initially focus on the design and manufacture of nanoparticles to supply Midatech Group's series of projects applying nanotechnology for therapeutic purposes. These include using nanoparticles as scaffolds for synthetic vaccines and antibiotics, as drug delivery vehicles for RNAi drugs and drugs able to cross the blood brain barrier, as well as targeted cancer treatments and imaging agents. Midatech's nanoparticles will allow drug companies to deliver new and existing medicines at significantly lower doses and with greater specificity, thereby reducing toxicity.

Source:
cemag.us

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project